MiR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC)

Biomedicine and Pharmacotherapy

Volumn 68, Issue 2, 2014, Pages 149-154

  Yungang, Wu ^a,b   Xiaoyu, Li ^b   Pang, Taizhong ^b   Wenming, Li ^a   Pan, Xinliang ^a  

^a SHANDONG UNIVERSITY   (China)

^b JINING MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; FoxM1; Laryngeal squamous cell carcinoma; MiR 370

Indexed keywords

FORKHEAD BOX M1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; MICRORNA; MICRORNA 370; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CANCER TISSUE; CELL PROLIFERATION; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION;

CELL PROLIFERATION; FOXM1; LARYNGEAL SQUAMOUS CELL CARCINOMA; MIR-370;

BASE SEQUENCE; BINDING SITES; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; HUMANS; LARYNGEAL NEOPLASMS; LUCIFERASES, RENILLA; MICRORNAS; MOLECULAR SEQUENCE DATA; PLASMIDS; TRANSFECTION; UP-REGULATION;

EID: 84897052191     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.08.008     Document Type: Article

References (39)

1. Marioni G., Marchese-Ragona R., Cartei G., Marchese F., Staffieri A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev 2006, 32:504-515.
2. Forastiere A.A., Trotti A., Pfister D.G., Grandis J.R. Head and neck cancer: recent advances and new standards of care. J Clin Oncol 2006, 24:2603-2605.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Rigoutsos I. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res 2009, 69:3245-3248.
5. Iorio M.V., Croce C.M. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009, 27:5848-5856.
6. Musiyenko A., Bitko V., Barik S. Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med 2008, 86:313-322.
7. Michael M.Z., O'Connor S.M., van Holst Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
8. Zhang Y., Yan L.X., Wu Q.N., et al. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 2011, 71:3552-3562.
9. Le H.B., Zhu W.Y., Chen D.D., et al. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med Oncol 2012, 29:3190-3197.
10. Guo J., Miao Y., Xiao B., et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009, 24:652-657.
11. Wang C.M., Wang Y., Fan C.G., et al. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. BBRC 2011, 411:586-592.
12. Metzler M., Wilda M., Busch K., Viehmann S., Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004, 39:167-169.
13. Li T., Li D., Sha J., Sun P., Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. BBRC 2009, 383:280-285.
14. Sun T., Wang Q., Balk S., Brown M., Lee G.S., Kantoff P. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 2009, 69:3356-3363.
15. Varambally S., Cao Q., Mani R.S., et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008, 322:1695-1699.
16. Saito Y., Liang G., Egger G., et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9:435-443.
17. Kong D., Li Y., Wang Z., et al. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009, 27:1712-1721.
18. Mott J.L., Kobayashi S., Bronk S.F., Gores G.J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140.
19. Wu Z., Sun H., Zeng W., He J., Mao X. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PloS One 2012, 7:e45825.
20. Zhang X., Zeng J., Zhou M., et al. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia. Mol Cancer 2012, 11:56.
21. An F., Yamanaka S., Allen S., et al. Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch. PloS One 2012, 7:e45606.
22. Meng F., Wehbe-Janek H., Henson R., Smith H., Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008, 27:378-386.
23. Hui A.B., Lenarduzzi M., Krushel T., et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010, 16:1129-1139.
24. Long X.B., Sun G.B., Hu S., et al. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep 2009, 22:1189-1195.
25. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004, 101:2999-3004.
26. Cimmino A., Calin G.A., Fabbri M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102:13944-13949.
27. Smeets S.J., Braakhuis B.J., Abbas S., et al. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006, 25:2558-2564.
28. Yu Y.H., Kuo H.K., Chang K.W. The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review. PloS One 2008, 3:e3215.
29. Mishra P.J., Humeniuk R., Mishra P.J., Longo-Sorbello G.S., Banerjee D., Bertino J.R. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A 2007, 104:13513-13518.
30. Guo Y., Fu W., Chen H., Shang C., Zhong M. miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein. Oncol Rep 2012, 27:1097-1103.
31. Wierstra I., Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem 2007, 388:1257-1274.
32. Wu Q.F., Liu C., Tai M.H., et al Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro. Acta Pharmacol Sin 2010, 31:361-366.
33. Zeng J., Wang L., Li Q., et al. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol 2009, 218:419-427.
34. Kim I.M., Ackerson T., Ramakrishna S., et al. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006, 66:2153-2161.
35. Kalin T.V., Wang I.C., Ackerson T.J., et al. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 2006, 66:1712-1720.
36. Bektas N., Haaf A., Veeck J., et al. Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer 2008, 8:42.
37. Bao B., Wang Z., Ali S., et al. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 2011, 112:2296-2306.
38. Bandres E., Cubedo E., Agirre X., et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006, 5:29.
39. Gao W., He H.W., Wang Z.M., et al. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis 2012, 11:55.